...
akya-img

Akoya Biosciences Inc, Common Stock

AKYA

NSQ

$2.27

-$0.16

(-6.58%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$126.39M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
121.23K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.35
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.88 L
$6.31 H
$2.27

About Akoya Biosciences Inc, Common Stock

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameAKYASectorS&P500
1-Week Return7.08%-2.27%-0.57%
1-Month Return-29.28%-3.96%1.21%
3-Month Return-22.79%-9.7%7.57%
6-Month Return3.18%-3.37%11.45%
1-Year Return-48.17%3.71%28.48%
3-Year Return-81.84%3.8%29.52%
5-Year Return-91.29%39.78%90.66%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue42.24M42.44M54.92M74.86M96.63M[{"date":"2019-12-31","value":43.71,"profit":true},{"date":"2020-12-31","value":43.92,"profit":true},{"date":"2021-12-31","value":56.83,"profit":true},{"date":"2022-12-31","value":77.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue17.57M16.54M20.70M31.47M40.33M[{"date":"2019-12-31","value":43.58,"profit":true},{"date":"2020-12-31","value":41,"profit":true},{"date":"2021-12-31","value":51.33,"profit":true},{"date":"2022-12-31","value":78.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit24.66M25.91M34.22M43.39M56.30M[{"date":"2019-12-31","value":43.8,"profit":true},{"date":"2020-12-31","value":46.01,"profit":true},{"date":"2021-12-31","value":60.77,"profit":true},{"date":"2022-12-31","value":77.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin58.39%61.04%62.31%57.96%58.27%[{"date":"2019-12-31","value":93.72,"profit":true},{"date":"2020-12-31","value":97.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.02,"profit":true},{"date":"2023-12-31","value":93.51,"profit":true}]
Operating Expenses38.17M37.40M71.44M109.60M104.27M[{"date":"2019-12-31","value":34.82,"profit":true},{"date":"2020-12-31","value":34.12,"profit":true},{"date":"2021-12-31","value":65.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.14,"profit":true}]
Operating Income(13.50M)(11.49M)(37.23M)(66.21M)(57.67M)[{"date":"2019-12-31","value":-1350400000,"profit":false},{"date":"2020-12-31","value":-1149200000,"profit":false},{"date":"2021-12-31","value":-3722500000,"profit":false},{"date":"2022-12-31","value":-6620800000,"profit":false},{"date":"2023-12-31","value":-5766800000,"profit":false}]
Total Non-Operating Income/Expense(2.93M)(7.38M)(6.89M)(8.19M)(10.79M)[{"date":"2019-12-31","value":-293400000,"profit":false},{"date":"2020-12-31","value":-737600000,"profit":false},{"date":"2021-12-31","value":-689200000,"profit":false},{"date":"2022-12-31","value":-818900000,"profit":false},{"date":"2023-12-31","value":-1078900000,"profit":false}]
Pre-Tax Income(14.56M)(16.66M)(43.08M)(70.52M)(63.28M)[{"date":"2019-12-31","value":-1455700000,"profit":false},{"date":"2020-12-31","value":-1666400000,"profit":false},{"date":"2021-12-31","value":-4307500000,"profit":false},{"date":"2022-12-31","value":-7051800000,"profit":false},{"date":"2023-12-31","value":-6328300000,"profit":false}]
Income Taxes194.00K42.00K(140.00K)123.00K40.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":21.65,"profit":true},{"date":"2021-12-31","value":-72.16,"profit":false},{"date":"2022-12-31","value":63.4,"profit":true},{"date":"2023-12-31","value":20.62,"profit":true}]
Income After Taxes(14.75M)(16.71M)(42.94M)(70.64M)(63.32M)[{"date":"2019-12-31","value":-1475100000,"profit":false},{"date":"2020-12-31","value":-1670600000,"profit":false},{"date":"2021-12-31","value":-4293500000,"profit":false},{"date":"2022-12-31","value":-7064100000,"profit":false},{"date":"2023-12-31","value":-6332300000,"profit":false}]
Income From Continuous Operations(14.75M)(16.71M)(42.94M)(70.64M)(71.40M)[{"date":"2019-12-31","value":-1475100000,"profit":false},{"date":"2020-12-31","value":-1670600000,"profit":false},{"date":"2021-12-31","value":-4293500000,"profit":false},{"date":"2022-12-31","value":-7064100000,"profit":false},{"date":"2023-12-31","value":-7139600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(14.75M)(16.71M)(42.94M)(70.64M)(63.32M)[{"date":"2019-12-31","value":-1475100000,"profit":false},{"date":"2020-12-31","value":-1670600000,"profit":false},{"date":"2021-12-31","value":-4293500000,"profit":false},{"date":"2022-12-31","value":-7064100000,"profit":false},{"date":"2023-12-31","value":-6332300000,"profit":false}]
EPS (Diluted)-(0.20)(4.52)(1.88)(1.43)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-20.5,"profit":false},{"date":"2021-12-31","value":-452,"profit":false},{"date":"2022-12-31","value":-188,"profit":false},{"date":"2023-12-31","value":-143,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AKYA
Cash Ratio 1.28
Current Ratio 2.75
Quick Ratio 1.85

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AKYA
ROA (LTM) -18.09%
ROE (LTM) -128.20%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AKYA
Debt Ratio Lower is generally better. Negative is bad. 0.90
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.10

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AKYA
Trailing PE NM
Forward PE NM
P/S (TTM) 1.21
P/B 8.25
Price/FCF NM
EV/R 1.86
EV/Ebitda NM

FAQs

What is Akoya Biosciences Inc share price today?

Akoya Biosciences Inc (AKYA) share price today is $2.27

Can Indians buy Akoya Biosciences Inc shares?

Yes, Indians can buy shares of Akoya Biosciences Inc (AKYA) on Vested. To buy Akoya Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AKYA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Akoya Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Akoya Biosciences Inc (AKYA) via the Vested app. You can start investing in Akoya Biosciences Inc (AKYA) with a minimum investment of $1.

How to invest in Akoya Biosciences Inc shares from India?

You can invest in shares of Akoya Biosciences Inc (AKYA) via Vested in three simple steps:

  • Click on Sign Up or Invest in AKYA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Akoya Biosciences Inc shares
What is Akoya Biosciences Inc 52-week high and low stock price?

The 52-week high price of Akoya Biosciences Inc (AKYA) is $6.31. The 52-week low price of Akoya Biosciences Inc (AKYA) is $1.88.

What is Akoya Biosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Akoya Biosciences Inc (AKYA) is

What is Akoya Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Akoya Biosciences Inc (AKYA) is 8.25

What is Akoya Biosciences Inc dividend yield?

The dividend yield of Akoya Biosciences Inc (AKYA) is 0.00%

What is the Market Cap of Akoya Biosciences Inc?

The market capitalization of Akoya Biosciences Inc (AKYA) is $126.39M

What is Akoya Biosciences Inc’s stock symbol?

The stock symbol (or ticker) of Akoya Biosciences Inc is AKYA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top